Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDIFAST INCMED · Entity 6587 | President, OPTAVIA | November 17, 2017 | November 17, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDIFAST INC
Report date November 17, 2017 · Filed November 17, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,809 |
Reported balance
After 2017-11-17 transaction · row 1
1 source rowRow 1 · 2017-11-17 · Tax withholding · Disposed 800 · Balance 10,809 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2017 Filed Nov 17, 2017 23:34 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 800 | $67.03 | $53,624.00 |
DisclosureSEC source: 0001144204-17-060011 · tv479892_form4.xml · nonDerivative · entry 1 AMELI MEHRNAZ MONA · CIK 0001625720 · President, OPTAVIA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,809 Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:58 UTC | MEDIFAST INC MED · Entity 6587 | GrantStock Options · Derivative | 7,500 | $0.00 Strike: $44.73 | $0.00 |
DisclosureSEC source: 0001144204-17-010268 · v460106_4.xml · derivative · entry 4 AMELI MEHRNAZ MONA · CIK 0001625720 · President, Take Shape For Life 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-02-16 F4 · shares: These non qualified stock options, which were issued to the reporting person under the 2012 Share Incentive Plan, will vest in three equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.exercise_date: These non qualified stock options, which were issued to the reporting person under the 2012 Share Incentive Plan, will vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:58 UTC | MEDIFAST INC MED · Entity 6587 | GrantPerformance Restricted Stock Units · Derivative | 37,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-010268 · v460106_4.xml · derivative · entry 3 AMELI MEHRNAZ MONA · CIK 0001625720 · President, Take Shape For Life 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,950 Underlying: Common Stock · 37,950 shares Expires not disclosed F3 · derivative.exercise_price: Represents the maximum number of shares that may be earned under this performance-based deferred share award. The actual number of deferred shares that will vest will be determined based on the achievement of certain pre-established performance goals, including the Company's total shareholder return and the price of the Common Stock, following the 2017 performance period. F3 · shares: Represents the maximum number of shares that may be earned under this performance-based deferred share award. The actual number of deferred shares that will vest will be determined based on the achievement of certain pre-established performance goals, including the Company's total shareholder return and the price of the Common Stock, following the 2017 performance period. F3 · derivative.exercise_date: Represents the maximum number of shares that may be earned under this performance-based deferred share award. The actual number of deferred shares that will vest will be determined based on the achievement of certain pre-established performance goals, including the Company's total shareholder return and the price of the Common Stock, following the 2017 performance period. F3 · derivative.expiration_date: Represents the maximum number of shares that may be earned under this performance-based deferred share award. The actual number of deferred shares that will vest will be determined based on the achievement of certain pre-established performance goals, including the Company's total shareholder return and the price of the Common Stock, following the 2017 performance period. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:58 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 2,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-010268 · v460106_4.xml · nonDerivative · entry 2 AMELI MEHRNAZ MONA · CIK 0001625720 · President, Take Shape For Life 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,489 F2 · shares: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest annually in equal installments over a period of three years, beginning on the first anniversary of the grant date. Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:58 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 2,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-010268 · v460106_4.xml · nonDerivative · entry 1 AMELI MEHRNAZ MONA · CIK 0001625720 · President, Take Shape For Life 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,369 F1 · shares: Represents shares issued to the reporting person under the 2012 Share Incentive Plan after pre-established performance -based conditions were satisfied for the 2016 performance period. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 21:10 UTC | MEDIFAST INC MED · Entity 6587 | Tax withholdingCommon Stock | 837 | $41.63 | $34,844.31 |
DisclosureSEC source: 0001144204-17-000581 · v456232_4.xml · nonDerivative · entry 1 AMELI MEHRNAZ MONA · CIK 0001625720 · President, Take Shape For Life 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,994 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.